NPI registry status
Active
2026 NPPES data Ophthalmology Physician NPI 1942380142 M.D.
Verify on CMS → Cesar Tort Sola, M.D.
Ophthalmology Physician in Caguas, Puerto Rico.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 22,082 in Ophthalmology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
4K
Medicare Part D claims · 664 beneficiaries · Ophthalmology Physician avg: 1K
Generic prescribing
0%
generic claims · 53% brand-name · higher generic rates reduce patient out-of-pocket costs
Source: CMS Medicare Part D Prescriber Public Use File, 2023
Compiled from official public sources by the PlainDoctor editorial team.
What the federal data shows
Cesar Tort Sola, M.D. filed 4,072 Medicare Part D claims in 2023 as a Ophthalmology Physician in Caguas, Puerto Rico, prescribing 0% generic.
- 4K
- Part D claims, 2023
- 0%
- generic prescribing
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Cesar Tort Sola, M.D.'s Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2023, across all CMS prescribers nationally
4,072 Top 8% higher than 92% of 1,370,886 prescribers
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Medicare Part D Prescriber Public Use File · 2023
◑
Board-eligible specialty (heuristic, not verified)
Cesar Tort Sola, M.D. practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Cesar Tort Sola, M.D.?
Quality data not reportedPrimary specialty
Ophthalmology Physician
Medicare Part D claims
4,072 187% vs specialty avg
Specialty distribution in Puerto Rico
How Ophthalmology Physician compares to other specialties among Puerto Rico providers
Board certification
Not published by CMS
CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Ophthalmology Physician. Verify directly:
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Cesar Tort Sola, M.D. appears in the CMS NPPES registry as an Ophthalmology Physician provider holding M.D. credentials at D4 AVE DEGETAU, Caguas, PR, 00725, with a listed phone of (787) 746-5777. NPI 1942380142 was issued on 10/16/2006.
Medicare Part D records for calendar year 2023 show 4,072 prescription claims written by this provider, covering 664 Medicare beneficiaries and totaling roughly $341K in drug spend, split 53% brand-name and 0% generic by claim count.
Ophthalmology Physician is a mid-sized specialty nationwide, with 22,082 enrolled providers across 56 states and an average of 1,420 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.
Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1942380142 |
|---|---|
| Specialty | Ophthalmology Physician |
| Credentials | M.D. |
| Gender | Male |
| NPI Issued | 10/16/2006 |
Brand vs generic prescribing mix · Brand-heavy
Cesar Tort Sola, M.D. - brand share 53.0%
Ophthalmology Physician average
53% brand-name claims vs 0% generic, on 4,072 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
4,072
Total Claims
$341K
Total Drug Cost
664
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 4,830
- Total Day Supply
- 121,986
- Brand vs Generic
- 53% brand / 0% generic
- Brand Drug Cost
- $291K
- Antibiotic Claims
- 15
Patient Demographics
- Average Patient Age
- 78.2 years
- Avg HCC Risk Score
- 1.74
- Gender Split
- 64% female / 36% male
- Age Distribution
- <65: 26, 65-74: 179, 75-84: 313, 85+: 146
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Cesar Tort Sola, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2023
- Latanoprost
Latanoprost
1,367 claims
- Brimonidine Tartrate 309
Brimonidine Tartrate
309 claims
- Restasis 297
Restasis
297 claims
- Prednisolone Acetate 275
Prednisolone Acetate
275 claims
- Dorzolamide-Timolol 269
Dorzolamide-Timolol
269 claims
- Tobramycin-Dexamet… 208
Tobramycin-Dexamethasone
208 claims
- Ketorolac Trometha… 187
Ketorolac Tromethamine
187 claims
- Ciprofloxacin Hcl 182
Ciprofloxacin Hcl
182 claims
| Drug | Claims |
|---|---|
| Latanoprost | 1,367 |
| Brimonidine Tartrate | 309 |
| Restasis Cyclosporine | 297 |
| Prednisolone Acetate | 275 |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 269 |
| Tobramycin-Dexamethasone Tobramycin/Dexamethasone | 208 |
| Ketorolac Tromethamine | 187 |
| Ciprofloxacin Hcl | 182 |
| Timolol Maleate | 155 |
| Erythromycin Erythromycin Base | 135 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Ophthalmology Physician Overview
How Cesar Tort Sola, M.D. fits within the Ophthalmology Physician landscape nationally.
22,082
Ophthalmology Physician Providers in US
56
States with Ophthalmology Physician
1,420
Avg Claims per Provider
Cesar Tort Sola, M.D.'s 4,072 claims are above the specialty average of 1,420.
Nearby Ophthalmology Physician Providers in Puerto Rico
Other clinicians with the same primary specialty enrolled in Puerto Rico, drawn from the same CMS NPPES roster as Tort Sola.
Dr. Alejandro Acosta Rivera
M.D.
San German, PR
Dr. Alejandro Acosta-Ortiz
MD
Cabo Rojo, PR
Dr. Luma Al-Attar
MD
Manati, PR
Dr. Luis Alcaraz
M.D.
Aguadilla, PR
Dr. Vicente Alcaraz
MD
San Juan, PR
Compare Ophthalmology Physician nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the Puerto Rico medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Ophthalmology Physician peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
How to Find a Doctor
Step-by-step guide to choosing a provider
Verify Credentials
Check NPI, board certification & license status
Medical Specialties Explained
Who treats what and how specialties differ
Understanding Medicare Claims Data
What prescribing data reveals about a provider
In-Network vs Out-of-Network
How insurance networks affect your costs
Telehealth Guide
Virtual care options and coverage in 2026
Explore Puerto Rico
Frequently Asked Questions
What is Cesar Tort Sola, M.D.'s specialty? ▼
Cesar Tort Sola, M.D. specializes in Ophthalmology Physician and practices in Caguas, Puerto Rico. Credentials: M.D..
How much does Cesar Tort Sola, M.D. prescribe under Medicare Part D? ▼
In 2023, Cesar Tort Sola, M.D. wrote 4,072 Medicare Part D claims totaling $341K in drug costs for 664 beneficiaries.
Where is Cesar Tort Sola, M.D. located? ▼
Cesar Tort Sola, M.D. is located at D4 AVE DEGETAU, Caguas, PR, 00725. Phone: (787) 746-5777.
What is Cesar Tort Sola, M.D.'s NPI number? ▼
Cesar Tort Sola, M.D.'s National Provider Identifier (NPI) is 1942380142, issued on 10/16/2006.
Does Cesar Tort Sola, M.D. prescribe more brand-name or generic drugs? ▼
Cesar Tort Sola, M.D.'s prescribing is 53% brand-name and 0% generic drugs by claim count, with $291K in brand drug costs.
How many Ophthalmology Physician providers are there in the US? ▼
There are 22,082 Ophthalmology Physician providers across 56 states in the US. The average Ophthalmology Physician provider writes 1,420 Medicare Part D claims per year.
What drugs does Cesar Tort Sola, M.D. prescribe most often? ▼
Based on 2023 Medicare Part D data, Cesar Tort Sola, M.D.'s most frequently prescribed drugs include Latanoprost, Brimonidine Tartrate, Restasis. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Cesar Tort Sola, M.D. accept Medicare? ▼
Cesar Tort Sola, M.D. appears in CMS Medicare data with 4,072 Part D claims and 664 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Cesar Tort Sola, M.D.'s credentials? ▼
Cesar Tort Sola, M.D.'s NPI is 1942380142 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Compiled from official public sources by the PlainDoctor editorial team.
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.